Amberstone Biosciences Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$12M
- Investors
-
6
Amberstone Biosciences General Information
Description
Developer of transformative therapeutic antibodies designed to benefit patients with unmet medical needs. The company's therapeutic antibodies use a microfluidics-based drug discovery engine to analyze single-cell function in a tunable microenvironment, enabling healthcare providers to improve the lives of patients.
Contact Information
Website
www.amberstonebio.comCorporate Office
- 15300 Barranca Parkway
- Suite 100 and 250
- Irvine, CA 92618
- United States
Corporate Office
- 15300 Barranca Parkway
- Suite 100 and 250
- Irvine, CA 92618
- United States
Amberstone Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 03-Jan-2022 | $12M | Completed | Pre-Clinical Trials | ||
| 4. Seed Round | 04-Nov-2021 | Completed | Pre-Clinical Trials | |||
| 3. Debt - PPP | 21-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jan-2021 | $1.23M | Completed | Pre-Clinical Trials | ||
| 1. Debt - PPP | 01-May-2020 | $144K | Completed | Pre-Clinical Trials |
Amberstone Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-2 | 3,250,000 | $0.000100 | 6% | $0.8 | $0.8 | 1x | $0.8 | 11.09% |
| Seed-1 | 1,803,600 | $0.000100 | 6% | $0.44 | $0.44 | 1x | $0.44 | 6.15% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Amberstone Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amberstone Biosciences Patents
Amberstone Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025259563-A2 | Anti-cd3 constructs and uses thereof | Pending | 10-Jun-2024 | ||
| WO-2025259563-A3 | Anti-cd3 constructs and uses thereof | Pending | 10-Jun-2024 | ||
| EP-4355785-A1 | Anti-cd3 constructs and uses thereof | Inactive | 17-Jun-2021 | ||
| US-12227574-B2 | Anti-cd3 constructs and uses thereof | Active | 17-Jun-2021 | ||
| US-20240279334-A1 | Anti-cd3 constructs and uses thereof | Active | 17-Jun-2021 | C07K16/2809 |
Amberstone Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amberstone Biosciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Changrong Capital | Venture Capital | Minority | ||
| Co-Win Ventures | Venture Capital | Minority | ||
| Lifespan Investments | Venture Capital | Minority | ||
| Sinovation Ventures | Venture Capital | Minority | ||
| Viva BioInnovator | Accelerator/Incubator | Minority |
Amberstone Biosciences FAQs
-
When was Amberstone Biosciences founded?
Amberstone Biosciences was founded in 2016.
-
Where is Amberstone Biosciences headquartered?
Amberstone Biosciences is headquartered in Irvine, CA.
-
What is the size of Amberstone Biosciences?
Amberstone Biosciences has 16 total employees.
-
What industry is Amberstone Biosciences in?
Amberstone Biosciences’s primary industry is Drug Discovery.
-
Is Amberstone Biosciences a private or public company?
Amberstone Biosciences is a Private company.
-
What is the current valuation of Amberstone Biosciences?
The current valuation of Amberstone Biosciences is .
-
What is Amberstone Biosciences’s current revenue?
The current revenue for Amberstone Biosciences is .
-
How much funding has Amberstone Biosciences raised over time?
Amberstone Biosciences has raised $15M.
-
Who are Amberstone Biosciences’s investors?
Changrong Capital, Co-Win Ventures, Lifespan Investments, Sinovation Ventures, and Viva BioInnovator are 5 of 6 investors who have invested in Amberstone Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
